CLASS III Drug recall · Reported 24 Oct 2018 · FDA Enforcement Report

Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg recalled

Mylan Pharmaceuticals is recalling Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, distributed nationwide in the US. The recall was initiated on 27 Aug 2018 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # 8508F004A; Exp. 02/20
Quantity recalled5,790 cartons (526,890 tablets)

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0025-2019
FDA event ID
81221
Recalling firm
Mylan Pharmaceuticals, Morgantown, WV
Classification
Class III
Status
Terminated
Recall initiated
27 Aug 2018
FDA classified
14 Oct 2018
Reported
24 Oct 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

27 Aug 2018Recall initiated by company
14 Oct 2018Classified by FDA+48 days
24 Oct 2018Published in enforcement report+10 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs.

Product as listed by the FDA

Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, Rx Only, 3 extended-cycle blister packs containing 91 tablets each, Made in India, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-7281-53.

Where it was distributed

Product was distributed throughout the United States.

Nationwide

Questions about this recall

Why was it recalled?

Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs.

Which lots are affected?

Lot # 8508F004A; Exp. 02/20

Where was it sold?

Product was distributed throughout the United States.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Mylan Pharmaceuticals

All 84

Other Levonorgestrel recalls

All 6